Vakzine Projekt Management GmbH Patent applications |
Patent application number | Title | Published |
20130337011 | RECOMBINANT MYCOBCTERIUM AS A VACCINE - The invention relates to a recombinant | 12-19-2013 |
20130280739 | DETERMINATION OF THE EFFICACY OF AN ANTI-MYCOBACTERIAL VACCINATION - The invention relates to methods and reagents for determining efficacy of vaccine, particularly of a tuberculosis vaccine. | 10-24-2013 |
20130280287 | RECOMBINANT MYCOBACTERIUM AS VACCINE FOR USE IN HUMANS - The invention relates to a recombinant vaccine providing protective immunity especially against tuberculosis in human subjects. | 10-24-2013 |
20130045230 | COMPOSITION CONTAINING HCMV PARTICLES - The present invention is related to a composition comprising an agent selected from the group comprising HCMV virions, HCMV dense bodies and HCMV NIEP, whereby the composition is capable of elucidating an immune response while the virions, the NIEP and/or the dense bodies being non-fusiogenic. | 02-21-2013 |
20130028935 | COMPOSITION CONTAINING HCMV PARTICLES - The present invention is related to a composition comprising an agent selected from the group comprising HCMV virions, HCMV dense bodies and HCMV NIEP, whereby the composition is capable of elucidating an immune response while the virions, the NIEP and/or the dense bodies being non-fusiogenic. | 01-31-2013 |
20080292656 | Combination of a Bacterial Cell and a Biologically Active Agent - The present invention is related to a combination comprising a first constituent and a second constituent, wherein the first constituent is a bacterial cell which comprises at least one recombinant nucleic acid molecule encoding a phagolysosomal escape peptide or polypeptide; and wherein the second constituent is a biologically active agent. In certain embodiments, the combination is of use as a vaccine to induce an immune response in a mammal. | 11-27-2008 |